Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-15
2006-08-15
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S203000, C548S204000, C548S235000, C548S236000, C514S374000
Reexamination Certificate
active
07091225
ABSTRACT:
Compounds of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein X is O or S X1 is O or S; X is S or O; R1 and R2 are independently H, methyl, or halogen; R4 and R5 are independently H or C1-3 alkyl or R4 and R5 may, together with the carbon atom to which they are bonded, form a 3–5 membered cycloalkyl ring; R6 and R7 are independently H, C1-3 alkyl, or allyl; each R3 is independently halogen, C1-6 straight or branched alkyl, or CF3; and y is 0, 1, 2, 3, 4 or 5 act as hPPAR alpha agonists.
REFERENCES:
patent: 6518290 (2003-02-01), Sierra
patent: 6706717 (2004-03-01), Barrish et al.
patent: 6710063 (2004-03-01), Chao et al.
patent: 6723740 (2004-04-01), Chao et al.
patent: 1 067 109 (2001-10-01), None
patent: 01/00603 (2001-04-01), None
patent: 01/40207 (2001-07-01), None
Fox Jennifer L.
Shameem Golam M. M.
SmithKline Beecham Corporation
LandOfFree
Substituted oxazoles and thiazoles as hPPAR alpha agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted oxazoles and thiazoles as hPPAR alpha agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted oxazoles and thiazoles as hPPAR alpha agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3670497